🇯🇵 日本語 🇺🇸 English
3,803 companies 7,534 AI summaries 6,131 risk analyses 2,986 growth scores Register free — watchlist & alerts →
EDINET 4935 Neutral Risk Analyzed 📈 Growth 6/10

LIBERTA CO.,LTD.

Semi-Annual Report - 31st Term(2026/01/01 - 2026/12/31) ／ 2026-08-07 16:01

Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).

EarningsM&AImpairmentVolumeNew ProductNew MarketM&A/Alliance
AI Summary 2026-08-07 16:13

H1 FY2026 revenue grew 15.1% to ¥4,837M, driven by FREEZETECH functional wear (+32.0%) and toiletries brands (+31.1%). However, operating loss widened to ¥375M and net loss reached ¥303M due to SG&A increase and ¥71M impairment loss. M&A of Clea Co. (100% acquisition/merger in June) strengthens skincare product development capabilities for mid-term growth target of ¥30B revenue by end of 2030.

KEY POINTS
  • Revenue +15.1% (¥4,205M → ¥4,837M) across six main product categories; functional apparel and toiletries lead with +32.0% and +31.1% growth respectively
  • Operating loss ¥375M (vs. loss of ¥135M in prior-year period); net loss ¥303M widened due to SG&A increases and ¥71M goodwill impairment charge
  • M&A strategy: 100% acquisition of Clea Co. in April, merged in June; leverages specialized skincare product development expertise to support medium-term goal of ¥30B revenue by Dec 2030
📊 Revenue
Revenue +15.1% (¥4,205M → ¥4,837M)
💰 Operating profit
Operating loss ¥375M (prior-year loss ¥135M); net loss ¥303M
🔮 Outlook
Not stated (mid-term targets: ¥30B revenue & ¥2B ordinary profit by end of Dec 2030)
📈 Growth outlook 📈 Growth 6/10
H1 revenue growth of +15.1% YoY is solid with functional apparel, toiletries, and cosmetics driving volume. M&A integration of Clea strengthens skincare expertise and drugstore distribution channels, supporting mid-term target of ¥30B revenue by 2030. However, operating losses persist, requiring profitability improvement.
Growth drivers
  • FREEZETECH functional wear expansion into sports retail and home centers drives +32.0% category growth
  • New toiletries brand Hedoro Tornado exceeds major chain adoption budget expectations significantly
  • Dentis oral care brand benefits from 2024 promotional momentum; new flavor and 20th-anniversary lineup boost cosmetics sales +16.4%
  • Clea M&A integration adds specialized skincare product development expertise and drugstore distribution foundation
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
CategoryDescriptionScoreNew
Financial Covenant Breach Risk Multiple commitment line contracts require 'ordinary profit ≥ ¥0' and 'operating profit ≥ ¥0' covenants. H1 ordinary loss of ¥407M indicates potential breach; risk of loan acceleration or covenant amendment demands. 8/10
Business Performance Deterioration Risk Operating losses persist with SG&A expanding and ¥71M impairment charges. Return to operating profitability remains uncertain; operating CF deteriorated to negative ¥1,077M despite revenue growth. 7/10
Liquidity Risk Operating CF negative ¥1,077M; seasonal inventory build (¥1,142M increase) drains liquidity. High reliance on short/long-term borrowing increases interest rate exposure and refinancing risk. 7/10
M&A Integration Risk Clea Co. acquisition (April) and merger (June) recently completed. Integration risks include unexpected cost increases, goodwill amortization burden, personnel/system integration issues, and failure to realize projected synergies. 6/10
Credit Risk Equity ratio of 17.5% is low; debt of ¥7,046M vs. equity of ¥1,513M. Credit rating of C (40/100) weakens funding access; refinancing costs and terms may deteriorate. 6/10
Impairment Loss Risk ¥71M goodwill impairment recognized on Fuji & Cherry (acquired 2023) due to cash flow underperformance. Additional impairment charges possible if other business segments underperform forecasts. 5/10
Customer Concentration Risk High concentration in drugstore and variety shop channels; significant exposure to major chains (e.g., Don Quijote). Risk of margin pressure, increased returns, or order reductions from key customers. 5/10
Raw Material & Supply Chain Risk Yen weakness drives raw material cost inflation; logistics and labor costs remain elevated. Inability to pass costs to customers risks margin contraction. 5/10
8/10 Financial Covenant Breach Risk
Multiple commitment line contracts require 'ordinary profit ≥ ¥0' and 'operating profit ≥ ¥0' covenants. H1 ordinary loss of ¥407M indicates potential breach; risk of loan acceleration or covenant amendment demands.
7/10 Business Performance Deterioration Risk
Operating losses persist with SG&A expanding and ¥71M impairment charges. Return to operating profitability remains uncertain; operating CF deteriorated to negative ¥1,077M despite revenue growth.
7/10 Liquidity Risk
Operating CF negative ¥1,077M; seasonal inventory build (¥1,142M increase) drains liquidity. High reliance on short/long-term borrowing increases interest rate exposure and refinancing risk.
6/10 M&A Integration Risk
Clea Co. acquisition (April) and merger (June) recently completed. Integration risks include unexpected cost increases, goodwill amortization burden, personnel/system integration issues, and failure to realize projected synergies.
6/10 Credit Risk
Equity ratio of 17.5% is low; debt of ¥7,046M vs. equity of ¥1,513M. Credit rating of C (40/100) weakens funding access; refinancing costs and terms may deteriorate.
5/10 Impairment Loss Risk
¥71M goodwill impairment recognized on Fuji & Cherry (acquired 2023) due to cash flow underperformance. Additional impairment charges possible if other business segments underperform forecasts.
5/10 Customer Concentration Risk
High concentration in drugstore and variety shop channels; significant exposure to major chains (e.g., Don Quijote). Risk of margin pressure, increased returns, or order reductions from key customers.
5/10 Raw Material & Supply Chain Risk
Yen weakness drives raw material cost inflation; logistics and labor costs remain elevated. Inability to pass costs to customers risks margin contraction.
X LinkedIn Threads Bluesky Facebook
Track Japanese disclosures with JSIGNAL

AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.

Start free — 30-day trial Login